Cargando…

756. Use Risk Factors to Early Screen Pneumocystis Pneumonia in Hospitalized Patients

BACKGROUND: The diagnosis of Pneumocystis pneumonia (PCP) may be delayed or missed if the underlying risk factors are not recognized, particularly in HIV-uninfected patients. METHODS: The adult hospitalized patients (≥18 years) with pneumonia were selected from the Nationwide Inpatient Sample databa...

Descripción completa

Detalles Bibliográficos
Autor principal:	Luo, Ruihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777831/ http://dx.doi.org/10.1093/ofid/ofaa439.946

Ejemplares similares

756. Clostridioides difficile Burden of Disease: A Prospective Population-Based Surveillance Study of Hospitalized Adults in Louisville, Kentucky
por: Furmanek, Stephen, et al.
Publicado: (2021)

336. COVID-19 and Pneumocystis jiroveci Pneumonia
por: Saling, Christopher, et al.
Publicado: (2021)

846. Pneumocystis Pneumonia in malignancy patients: Who is at risk?
por: Vasiloudes, Kritos, et al.
Publicado: (2023)

756. Factors that Increase Engagement on Social Media for an Infectious Diseases Fellowship Program
por: Cherian, John, et al.
Publicado: (2023)

1251. Prevention of Pneumocystis Pneumonia by Ibrexafungerp in a Murine Prophylaxis Model
por: Borroto-Esoda, Katyna, et al.
Publicado: (2020)

756. Targeting the Birth-Cohort of the Pre-antibiotic Era: A Proposal to Screen for Tuberculosis in Seniors in Arkansas
por: Gu, Mofan, et al.
Publicado: (2018)

1130. Low Risk of Pneumocystis jiroveci Pneumonia in Patients With Waldenstrom’s Macroglobulinemia on Ibrutinib
por: Kusztos, Amanda E, et al.
Publicado: (2018)

Pneumocystis pneumonia in a child with sojia
por: Schüller, Marcel, et al.
Publicado: (2014)

744. Clinical Performance of Real-time PCR in the Diagnosis of Pneumocystis jirovecii Pneumonia compared with Immunofluorescence Assay
por: Veintimilla, Cristina, et al.
Publicado: (2020)

P756: IMPAIRED MITOCHONDRIAL FUNCTION AND MARROW FAILURE IN PATIENTS CARRYING A MUTATION ON SRSF4 GENE
por: Miano, Maurizio, et al.
Publicado: (2023)

756. Impact of Infectious Diseases Pharmacists as Part of an Interdisciplinary OPAT Team Managing Vancomycin
por: Adamsick, Meagan L, et al.
Publicado: (2019)

145. the Efficacy and Safety of Low Dose Trimethoprim-sulfamethoxazole for the Treatment of Pneumocystis Pneumonia: A Systematic Review and Meta-analysis
por: Tritle, Brandon, et al.
Publicado: (2020)

Outcome and prognostic factors in patients with HIV-negative pneumocystis pneumonia requiring mechanical ventilation
por: Choi, E
Publicado: (2010)

826. Decision to Treat Pneumocystis Jirovecii Pneumonia by Combining Molecular Diagnostics and Patient Specific Factors
por: Maro, Anna W, et al.
Publicado: (2023)

803. Risk factors associated with Clostridioides difficile infection in hospitalized patients with community-acquired pneumonia
por: Moore, William Justin, et al.
Publicado: (2020)

944. Pneumocystis-Tuberculosis Co-infection in the HIV Positive Host
por: Nair, Sashi N, et al.
Publicado: (2020)

1024. Evaluation of Atovaquone Prescribing for Pneumocystis jiroveci Pneumonia (PJP) Prophylaxis
por: Aleissa, Muneerah, et al.
Publicado: (2019)

402. Breakthrough Pneumocystis jirovecii Pneumonia Among Cancer Patients: Opportunity for Antimicrobial Stewardship?
por: Roncaioli, Steven, et al.
Publicado: (2018)

Characteristics and Outcomes of Patients with Pneumocystis jirovecii Pneumonia Who Were Initiated on Antiretroviral Therapy While Hospitalized: A Preliminary Study
por: Shah, Pooja, et al.
Publicado: (2017)

1171. Lower Mortality with Adjuvant Corticosteroid Therapy in non-HIV Infected Patients with pneumocystis jirovecii pneumonia: A Single US Cohort Study and a Proposed Novel Mechanism of Corticosteroids
por: Mundo, William, et al.
Publicado: (2020)

Risk factors of in-hospital mortality in patients with pneumocystis pneumonia diagnosed by metagenomics next-generation sequencing
por: Hou, Jun-Na, et al.
Publicado: (2022)

P1565: INCIDENCE OF PNEUMOCYSTIS JIROVECII PNEUMONIA IN PATIENTS WITH B-LINEAGE LYMPHOMA RECEIVING CHEMOTHERAPY CONTAINING RITUXIMAB
por: Liang, Xiping Xiping, et al.
Publicado: (2023)

Clinical and translational research in Pneumocystis and Pneumocystis pneumonia
por: Huang, L.
Publicado: (2011)

756 Emergency Department Visits During Outpatient Parenteral Antimicrobial Therapy (OPAT) Administered at Home
por: Shrestha, Nabin, et al.
Publicado: (2014)

527. Lower Risk of ICU Admission with Remdesivir in Patients Hospitalized with COVID-19 Pneumonia
por: Lim, Sarah, et al.
Publicado: (2021)

Usefulness of ß-d-Glucan Assay for the First-Line Diagnosis of Pneumocystis Pneumonia and for Discriminating between Pneumocystis Colonization and Pneumocystis Pneumonia
por: Bigot, Jeanne, et al.
Publicado: (2022)

EVALUATING PNEUMOCYSTIS JIROVECII PNEUMONIA (PCP) PROPHYLAXIS IN PATIENTS WITH GLIOMA RECEIVING CONCURRENT TEMOZOLOMIDE AND RADIATION – A PATIENT AND PHYSICIAN SURVEY
por: Beltran-Bless1, Ana-Alicia, et al.
Publicado: (2023)

Changing Trends in the Epidemiology and Risk Factors of Pneumocystis Pneumonia in Spain
por: Pereira-Díaz, Estefanía, et al.
Publicado: (2019)

1486. Missed and Delayed Diagnosis of Pneumocystis Pneumonia in HIV and Non-HIV-Infected Individuals
por: Miller, Aaron, et al.
Publicado: (2018)

Incidence and Risk Factors for Infections Requiring Hospitalization, Including Pneumocystis Pneumonia, in Japanese Patients with Rheumatoid Arthritis
por: Hashimoto, Atsushi, et al.
Publicado: (2017)

Pneumocystis jiroveci Pneumonia
por: Haque, Abida K., et al.
Publicado: (2008)

P1526: THE RISK OF DEVELOPING PNEUMOCYSTIS JIROVECII PNEUMONIA PERSISTS EVEN AFTER COMPLETION OF IMMUNOSUPPRESSANTS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS
por: Ara, Takahide, et al.
Publicado: (2023)

Pneumocystis pneumonia in HIV-positive patients in Spain: epidemiology and environmental risk factors
por: Alvaro-Meca, Alejandro, et al.
Publicado: (2015)

Fr495 INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH SIGNIFICANTLY WORSENED CLINICAL OUTCOMES OF COVID-19 INFECTION IN A RETROSPECTIVE ANALYSIS OF 78,756 PATIENTS ACROSS 143 HOSPITALS
por: Zackria, Rasiq, et al.
Publicado: (2021)

2695. Pneumocystis jirovecii Pneumonia in the Era of Effective Prophylaxis Following Hematopoietic Stem Cell Transplant
por: Drelick, Alexander Christian, et al.
Publicado: (2019)

830. Risk factors for late Pneumocystis jirovecii pneumonia in kidney transplant recipients: A Case-Control Study of United States Renal Data System Data
por: Mendoza, Maria Alejandra, et al.
Publicado: (2023)

Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients
por: Lee, Su Hwan, et al.
Publicado: (2017)

Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer
por: Lee, Eun Hye, et al.
Publicado: (2019)

2174. A 10-Year Review of Infection Burden in Hospitalized Burn Patients in the United States
por: Luo, Ruihong
Publicado: (2018)

Direct and heterologous approaches to identify the LET-756/FGF interactome
por: Popovici, Cornel, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_aamf9bu5imp4j2g4kppgj8vncp